Charles River Laboratories | CRL - Cash And Equivalent



Charles River Laboratories reported $182.82M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Agilent USD 1.54B 49M Jul/2025
Align Technology USD 873.01M 170.88M Mar/2025
Bio-Rad Laboratories USD 369.3M 152.1M Jun/2025
Bruker USD 92M 92.2M Jun/2025
Cardinal Health USD 3.87B 548M Jun/2025
Charles River Laboratories USD 182.82M 46.53M Jun/2025
Cigna USD 4.33B 4B Jun/2025
CVS Health USD 11.79B 1.71B Jun/2025
Danaher USD 2.96B 964M Jun/2025
Dentsply International USD 359M 39M Jun/2025
Elevance Health USD 8.56B 1.06B Jun/2025
Galapagos EUR 108.07M 43.83M Mar/2025
Hologic USD 1.74B 305.7M Jun/2025
Humana USD 4.04B 210M Jun/2025
Illumina USD 934M 179M Jun/2025
Incyte USD 2.42B 13.08M Jun/2025
IQVIA Holdings USD 2.04B 299M Jun/2025
Laboratory Of America USD 647.3M 277.9M Jun/2025
Lonza CHF 1.11B 286M Dec/2024
McKesson USD 2.42B 3.27B Jun/2025
Merck EUR 1.17B 161M Jun/2025
Mettler Toledo International USD 61.82M 2.47M Jun/2025
Novartis USD 6.66B 410M Jun/2025
Pfizer USD 1.64B 208M Jun/2025
Quest Diagnostics USD 319M 131M Jun/2025
Revvity USD 991.85M 145.77M Jun/2025
Thermo Fisher Scientific USD 4.58B 442M Jun/2025
United Therapeutics USD 1.59B 306.8M Jun/2025
UnitedHealth USD 32.02B 2.27B Jun/2025
Waters USD 367.22M 15.66M Jun/2025
West Pharmaceutical Services USD 509.7M 105.5M Jun/2025